DOCSLIB.ORG

Tenascin in Cerebrospinal Fluid Is a Useful Biomarker for the Diagnosis of Brain Tumour

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tenascin in Cerebrospinal Fluid Is a Useful Biomarker for the Diagnosis of Brain Tumour 121212ournal ofNeurology, Neurosurgery, and Psychiatry 1994;57:1212-1215 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.57.10.1212 on 1 October 1994. Downloaded from Tenascin in cerebrospinal fluid is a useful biomarker for the diagnosis of brain tumour J Yoshida, T Wakabayashi, S Okamoto, S Kimura, K Washizu, K Kiyosawa, K Mokuno Abstract Subsequently, Erikson and Taylor showed Tenascin, an extracellular matrix glyco- that this was biochemically identical with protein, has been reported to be tenascin.6 Within the CNS the use of peroxi- expressed predominantly on glioma tis- dase antiperoxidase immunohistology with sue in the CNS, both in a cell associated 81 C6 MCA showed that the antigen was and an excreted form. Recently, a highly expressed in glioblastomas but not in astrocy- sensitive sandwich type enzyme tomas or in normal adult brain.7 immunoassay for quantitative determi- In 1991, Herlyn et al found that most nation of tenascin was developed. In the melanoma cells secreted tenascin in vitro. present study, the amount of tenascin in They also reported that tenascin was present CSF was measured. An increase of in the serum of patients with melanoma and tenascin in CSF (>100 nglml) was found that the concentration of tenascin in serum in patients with an astrocytic tumour. was a tumour marker for advanced The concentration was significantly melanomas because they found lower concen- higher (>300 nglrn) in high grade astro- trations in patients with low tumour burden cytoma (anaplastic astrocytoma and and in normal donors.8 Recently, we devel- glioblastoma) and a further increase oped a sandwich type enzyme immunoassay (>1000 ng/ml) was found in cases of CSF for tenascin9 and showed, with this assay sys- dissemination ofhigh grade astrocytoma. tem, that not only human melanoma, but also On the other hand, tenascin concentra- human lung cancer and glioma cells secreted tions were less than 100 nglml in non- 1-14 jug/ml of tenascin in vitro (data not astrocytic tumours and non-neoplastic shown). In the present study, serum and CSF neurological diseases, except meningeal were obtained from patients with various neo- dissemination of tumour cells, meningeal plastic and non-neoplastic neurological dis- stimulation by infection, and subarach- eases, and the amount of tenascin was noid haemorrhage. In cases of treated quantitatively determined. It was expected astrocytomas in remission, tenascin was that an increased level of expression of this negligible (<100 ng/ml) in the CSF. The extracellular matrix glycoprotein would be measurement oftenascin in CSF is useful found in neoplasms compared with other dis- for differential diagnosis of brain eases of the CNS, and that the level of expres- tumours and monitoring of astrocytic sion would be useful in indicating the type of http://jnnp.bmj.com/ Department of tumours. brain tumour. Neurosurgery, Nagoya University School of Medicine, Nagoya, (7 Neurol Neurosurg Psychiatry 1994;57:1212-1215) Japan Patients and methods J Yoshida SANDWICH TYPE ENZYME IMMUNOASSAY T Wakabayashi S Okamoto Tenascin is an extracellular matrix glycopro- Details of the methodology of the sandwich Department of tein involved in tissue interaction during fetal type enzyme immunoassay for tenascin has on September 25, 2021 by guest. Protected copyright. Research and development and oncogenesis. Chiquet- been reported elsewhere.9 Briefly, an anti- Development, Amano Ehrismann et al reported that tenascin was serum to human tenascin was raised in rab- Pharmaceutical Company, Aichi, present in the mesenchyme of the fetal rat bits. Two antihuman tenascin monoclonal Japan mammary gland but not in the adult mam- antibodies, 8C9 (RCBl)'0 and 9B2, were sup- S Kimura mary gland. The protein was, however, pre- plied by Amano Pharmaceutical Co, Aichi, K Washizu dominantly re-expressed in carcinogen Japan and F(ab)'2 fragments of both antibod- Department of induced mammary tumours.1 This extracellu- ies, prepared from lgG by pepsin digestion, Neurology, Nagoya University School of lar matrix glycoprotein was discovered inde- were used. The RCB1 fragment was immo- Medicine, Nagoya, pendently by several laboratories, each bilised non-covalently on polystyrene beads Japan showing a different aspect of its biology, and and the 9B2 fragment was coupled to ,B3D- K Kiyosawa K Mokuno each giving it a different name: myotendinous galactosidase. Polystyrene beads with anti- were with various amounts Correspondence to: antigen,2 glioma mesenchymal extracellular bodies incubated Dr Jun Yoshida, matrix antigen,'3 Jl glycoprotein,4 cytotactin,5 of purified tenascin or samples of serum and Departmnent of ml Neurosurgery, Nagoya hexabrachion,6 and tenascin.1 Bourdor et al CSF (10 Ml) in a final volume of 051 with University School of reported a glioma mesenchymal extracellular sodium phosphate buffer for three hours. Medicine, 65 Tsurumai- cho, Showa-ku, Nagoya, matrix antigen defined by monoclonal anti- After washing twice with buffer, the beads 466 Japan. body 81 C6, which binds an extracellular were left standing overnight with 1 mU of ,B Received 19 March 1993 matrix antigen shared by glioma and mes- D-galatosidase labelled antibodies (mixed 0 5 and in final revised form 28 January 1994. enchymal cell lines but not carcinoma, mU of 8C9 and 9B2) in 02 ml of buffer solu- Accepted 1 March 1994 myeloid, or lymphoid cell lines.7 tion at 4°C. Beads were again washed twice Tenascin in cerebrospinalfluid is a useful biomarkerfor the diagnosis of brain tumour 1213 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.57.10.1212 on 1 October 1994. Downloaded from Table 1 Concentrations of tenascin in CSF (nglml) Table 2 Numbers ofpatients with non-neoplastic diseases Negligible Low Medium High Non-neoplastic disease n Disease n (<100) (100-300) (300-1000) (>1000) Cerebral infarction 9 Intracerebral haemorrhage 1 Non-neoplastic disease 57 54 3§ 0 0 Subarachnoid haemorrhage 3 Pituitary adenoma 10 10 0 0 0 Meningitis or encephalitis 9 Craniopharyngioma 2 2 0 0 0 Cervical or lumbar spondylosis 9 Neurinoma 2 2 0 0 0 Multiple sclerosis 4 Meningioma 6 5 1* 0 0 Spinocerebellar degeneration 6 Germ cell tumour 4 4 0 0 0 Amyotrophic lateral sclerosis Pineoblastoma 1 1 0 0 0 Parkinson's disease l CNS lymphoma 1 0 1 0 0 Huntington's disease Oligodendroglioma 1 1 0 0 0 Bulbospinal muscular atrophy Ependymoma 1 1 0 0 0 Neuropathy 3 Medulloblastoma 2 1 0 1* 0 Dementia 1 Astrocytoma 5 it 4 0 0 Involuntary movement 1 Anaplastic astrocytoma 5 it 0 3 1* Normal pressure hydrocephalus Glioblastoma 9 2t 3 2 2* Aneurysm 2 Brainstem glioma 6 3t 1 2 0 Radiation necrosis l Metastatic brain tumour 3 1 1 1 0 Arachnoid cyst Tuberculosis 1 *Associated with CSF dissemination. Head injury 1 tPostoperative state after radiotherapy or chemotherapy. *Meningeal sarcoma. SMeningitis, subarachnoid haemorrhage, normal pressure hydrocephalus. with chilled buffer and the galactosidase activ- astrocytoma or glioblastoma (n = 14). The ity bound was measured after incubation at concentrations of tenascin were statistically 37°C for 30 minutes with 0-15 mmol different between the groups. (fig 2) In the 4-methylumbelliferyl f,-D-galactoside (Sigma non-astrocytic group, tenascin in CSF was St Louis, MO, USA) as a substrate. less than 100 ng/ml except for three tumours (10%) each with CSF dissemination. More SAMPLES than 100 ng/ml of tenascin was detected in 15 Serum samples were obtained from two cases (79 0%) in the astrocytic tumour group. healthy donors and 10 patients with brain In three metastatic tumours, the level was tumours. Samples of CSF were taken from 249-7 ng/ml in meningeal carcinomatosis of patients with various neurological diseases by gastric cancer, 771-7 ng/ml in metastatic pari- spinal tap or puncture of an Ommaya reser- etal tumour of lung cancer, but only 45-5 voir connected to the lateral ventricle. Fifty ng/ml in an extradural skull base undifferenti- eight patients had brain tumours. (table 1) ated carcinoma. We classified the concentra- Samples of CSF from four patients were taken tion of tenascin in CSF into four groups; serially and the concentrations of tenascin negligible if less than 100 ng/ml, low if were compared with the tumour progression 100-300 ng/ml, medium when 300-1000 and regression. Fifty seven patients had non- ng/ml, and high for more than 1000 ng/ml neoplastic neurological disease (table 2). (table 1). In low grade astrocytoma, 80% of Brain tumour cystic fluid was also obtained the tumours expressed low concentrations of from eight patients at surgery or by puncture tenascin and, none of them had medium or of an Ommaya reservoir connected to the high concentrations, whereas more than 50% cyst. of high grade astrocytomas (anaplastic astro- http://jnnp.bmj.com/ cytoma or glioblastoma) expressed medium or high concentrations. Furthermore, all patients Results with high expression of tenascin showed CSF STANDARD CURVE Figure 1 shows a standard curve for our sand- wich type enzyme immunoassay of tenascin. * The minimum detectable amount of tenascin 700 on September 25, 2021 by guest. Protected copyright. 4)C was 0o 1 ng per assay tube or 10 ng/ml. A linear dose response of the absorbance v tenascin - 600 0) was at between 0 1 to 30 ng 40 added obtained -E C per assay tube. The results for diluted CSF S 500 .'' 0) samples were parallel with the standard curve. LL :: aoC.) 0) 3400 aJ0 CEREBROSPINAL FLUID Table 1 shows the concentrations of tenascin C1u 300 *; in CSF obtained from patients with various Ci) neurological diseases. For non-neoplastic dis- R 200 ease, 54 patients (94 8%) had tenascin con- 3 30 300 3000 centrations of less than 100 ng/ml and most 100 i Tenascin were less than 50 ng/ml.
Load more

Recommended publications
  • Global Analysis Reveals the Complexity of the Human Glomerular Extracellular Matrix
    Global analysis reveals the complexity of the human glomerular extracellular matrix Rachel Lennon,1,2 Adam Byron,1,* Jonathan D. Humphries,1 Michael J. Randles,1,2 Alex Carisey,1 Stephanie Murphy,1,2 David Knight,3 Paul E. Brenchley,2 Roy Zent,4,5 and Martin J. Humphries.1 1Wellcome Trust Centre for Cell-Matrix Research, Faculty of Life Sciences, University of Manchester, Manchester, UK; 2Faculty of Medical and Human Sciences, University of Manchester, Manchester, UK; 3Biological Mass Spectrometry Core Facility, Faculty of Life Sciences, University of Manchester, Manchester, UK; 4Division of Nephrology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; and 5Veterans Affairs Hospital, Nashville, TN, USA. *Present address: Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK. Running title: Proteome of the glomerular matrix Word count: Abstract: 208, main text 2765 Corresponding author: Dr Rachel Lennon, Wellcome Trust Centre for Cell-Matrix Research, Michael Smith Building, University of Manchester, Manchester M13 9PT, UK. Phone: 0044 (0) 161 2755498. Fax: 0044 (0) 161 2755082. Email: [email protected] Abstract The glomerulus contains unique cellular and extracellular matrix (ECM) components, which are required for intact barrier function. Studies of the cellular components have helped to build understanding of glomerular disease; however, the full composition and regulation of glomerular ECM remains poorly understood. Here, we employed mass spectrometry–based proteomics of enriched ECM extracts for a global analysis of human glomerular ECM in vivo and identified a tissue-specific proteome of 144 structural and regulatory ECM proteins. This catalogue includes all previously identified glomerular components, plus many new and abundant components.
    [Show full text]
  • Bruch's Membrane Abnormalities in PRDM5-Related Brittle Cornea
    Porter et al. Orphanet Journal of Rare Diseases (2015) 10:145 DOI 10.1186/s13023-015-0360-4 RESEARCH Open Access Bruch’s membrane abnormalities in PRDM5-related brittle cornea syndrome Louise F. Porter1,2,3, Roberto Gallego-Pinazo4, Catherine L. Keeling5, Martyna Kamieniorz5, Nicoletta Zoppi6, Marina Colombi6, Cecilia Giunta7, Richard Bonshek2,8, Forbes D. Manson1 and Graeme C. Black1,9* Abstract Background: Brittle cornea syndrome (BCS) is a rare, generalized connective tissue disorder associated with extreme corneal thinning and a high risk of corneal rupture. Recessive mutations in transcription factors ZNF469 and PRDM5 cause BCS. Both transcription factors are suggested to act on a common pathway regulating extracellular matrix genes, particularly fibrillar collagens. We identified bilateral myopic choroidal neovascularization as the presenting feature of BCS in a 26-year-old-woman carrying a novel PRDM5 mutation (p.Glu134*). We performed immunohistochemistry of anterior and posterior segment ocular tissues, as expression of PRDM5 in the eye has not been described, or the effects of PRDM5-associated disease on the retina, particularly the extracellular matrix composition of Bruch’smembrane. Methods: Immunohistochemistry using antibodies against PRDM5, collagens type I, III, and IV was performed on the eyes of two unaffected controls and two patients (both with Δ9-14 PRDM5). Expression of collagens, integrins, tenascin and fibronectin in skin fibroblasts of a BCS patient with a novel p.Glu134* PRDM5 mutation was assessed using immunofluorescence. Results: PRDM5 is expressed in the corneal epithelium and retina. We observe reduced expression of major components of Bruch’s membrane in the eyes of two BCS patients with a PRDM5 Δ9-14 mutation.
    [Show full text]
  • Immunohistochemical Expression of Tenascin and Elastin In
    Clinical Obstetrics, Gynecology and Reproductive Medicine Research Article ISSN: 2059-4828 Immunohistochemical expression of tenascin and elastin in women with pelvic organ prolapse and/or without stress urinary incontinence Ilias Liapis1, Panagiotis Bakas2, Pafiti-Kondi Agatha3, Matrona Frangou-Plemenou4, Charalampos Karachalios5*, Dimos Sioutis6 and Aggelos Liapis2 1Birmingham Women’s and Children’s Hospital, NHS Foundation Trust, Health Education England Midlands and East-West Midlands, Birmingham, England, United Kingdom 2Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, School of Health Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece 3Pathology Laboratory, Aretaieio University Hospital, School of Health Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece 4Microbiology Laboratory, Aretaieio University Hospital, School of Health Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece 5Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, School of Health Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece 6Third Department of Obstetrics and Gynecology, Attikon University Hospital, School of Health Sciences, Medical School, National and Kapodistrian University of Athens, Athens, Attica, Greece Abstract Background and aim: Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) constitute entities of pelvic floor disorders and most often occur simultaneously in the same patient, adversely affecting women’s quality of life. The pathogenesis of pelvic organ prolapse and stress urinary incontinence is not fully understood. The pelvic viscera are maintained in their place thanks to interconnection of levator ani muscles, cardinal and uterosacral ligaments, and pubocervical and rectovaginal fascia. Ligaments and fascia consist mainly of connective tissue.
    [Show full text]
  • Integrin Adhesion Molecules in the Human Endometrium. Correlation with the Normal and Abnormal Menstrual Cycle
    Integrin adhesion molecules in the human endometrium. Correlation with the normal and abnormal menstrual cycle. B A Lessey, … , S M Albelda, C A Buck J Clin Invest. 1992;90(1):188-195. https://doi.org/10.1172/JCI115835. Research Article Integrins are a class of cell adhesion molecules that participate in cell-cell and cell-substratum interactions and are present on essentially all human cells. The distribution of nine different alpha and beta integrin subunits in human endometrial tissue at different stages of the menstrual cycle was determined using immunoperoxidase staining. Glandular epithelial cells expressed primarily alpha 2, alpha 3, and alpha 6 (collagen/laminin receptors), while stromal cells expressed predominantly alpha 5 (fibronectin receptor). The presence of alpha 1 on glandular epithelial cells was cycle specific, found only during the secretory phase. Expression of both subunits of the vitronectin receptor, alpha v beta 3, also underwent cycle specific changes on endometrial epithelial cells. Immunostaining for alpha v increased throughout the menstrual cycle, while the beta 3 subunit appeared abruptly on cycle day 20 on luminal as well as glandular epithelial cells. Discordant luteal phase biopsies (greater than or equal to 3 d "out of phase") from infertility patients exhibited delayed epithelial beta 3 immunostaining. These results demonstrate similarities, as well as specific differences, between endometrium and other epithelial tissues. Certain integrin moieties appear to be regulated within the cycling endometrium and disruption of integrin expression may be associated with decreased uterine receptivity and infertility. Find the latest version: https://jci.me/115835/pdf Integrin Adhesion Molecules in the Human Endometrium Correlation with the Normal and Abnormal Menstrual Cycle Bruce A.
    [Show full text]
  • Supplementary Table 1: Adhesion Genes Data Set
    Supplementary Table 1: Adhesion genes data set PROBE Entrez Gene ID Celera Gene ID Gene_Symbol Gene_Name 160832 1 hCG201364.3 A1BG alpha-1-B glycoprotein 223658 1 hCG201364.3 A1BG alpha-1-B glycoprotein 212988 102 hCG40040.3 ADAM10 ADAM metallopeptidase domain 10 133411 4185 hCG28232.2 ADAM11 ADAM metallopeptidase domain 11 110695 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 195222 8038 hCG40937.4 ADAM12 ADAM metallopeptidase domain 12 (meltrin alpha) 165344 8751 hCG20021.3 ADAM15 ADAM metallopeptidase domain 15 (metargidin) 189065 6868 null ADAM17 ADAM metallopeptidase domain 17 (tumor necrosis factor, alpha, converting enzyme) 108119 8728 hCG15398.4 ADAM19 ADAM metallopeptidase domain 19 (meltrin beta) 117763 8748 hCG20675.3 ADAM20 ADAM metallopeptidase domain 20 126448 8747 hCG1785634.2 ADAM21 ADAM metallopeptidase domain 21 208981 8747 hCG1785634.2|hCG2042897 ADAM21 ADAM metallopeptidase domain 21 180903 53616 hCG17212.4 ADAM22 ADAM metallopeptidase domain 22 177272 8745 hCG1811623.1 ADAM23 ADAM metallopeptidase domain 23 102384 10863 hCG1818505.1 ADAM28 ADAM metallopeptidase domain 28 119968 11086 hCG1786734.2 ADAM29 ADAM metallopeptidase domain 29 205542 11085 hCG1997196.1 ADAM30 ADAM metallopeptidase domain 30 148417 80332 hCG39255.4 ADAM33 ADAM metallopeptidase domain 33 140492 8756 hCG1789002.2 ADAM7 ADAM metallopeptidase domain 7 122603 101 hCG1816947.1 ADAM8 ADAM metallopeptidase domain 8 183965 8754 hCG1996391 ADAM9 ADAM metallopeptidase domain 9 (meltrin gamma) 129974 27299 hCG15447.3 ADAMDEC1 ADAM-like,
    [Show full text]
  • Integrins: Roles in Cancer Development and As Treatment Targets
    British Journal of Cancer (2004) 90, 561 – 565 & 2004 Cancer Research UK All rights reserved 0007 – 0920/04 $25.00 www.bjcancer.com Minireview Integrins: roles in cancer development and as treatment targets 1 ,1,2 H Jin and J Varner* 1John and Rebecca Moores Comprehensive Cancer Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA; 2Department of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0912, USA The integrin family of cell adhesion proteins promotes the attachment and migration of cells on the surrounding extracellular matrix (ECM). Through signals transduced upon integrin ligation by ECM proteins or immunoglobulin superfamily molecules, this family of proteins plays key roles in regulating tumour growth and metastasis as well as tumour angiogenesis. Several integrins play key roles in promoting tumour angiogenesis and tumour metastasis. Antagonists of several integrins (a5b1, avb3 and avb5) are now under evaluation in clinical trials to determine their potential as therapeutics for cancer and other diseases. British Journal of Cancer (2004) 90, 561 – 565. doi:10.1038/sj.bjc.6601576 www.bjcancer.com & 2004 Cancer Research UK Keywords: angiogenesis; metastasis; apoptosis; integrin a5b1; integrin avb3 During the last 10 years, novel insights into the mechanisms sequences (e.g., integrin a4b1 recognises EILDV and REDV in that regulate cell survival as well as cell migration and invasion alternatively spliced CS-1 fibronectin). Inhibitors of integrin have led to the development of novel integrin-based therapeutics function include function-blocking monoclonal antibodies, pep- for the treatment of cancer. Several integrins play important tide antagonists and small molecule peptide mimetics matrix roles in promoting cell proliferation, migration and survival (reviewed in Hynes, 1992; Cheresh, 1993).
    [Show full text]
  • The Dynamic Interaction Between Extracellular Matrix Remodeling and Breast Tumor Progression
    cells Review The Dynamic Interaction between Extracellular Matrix Remodeling and Breast Tumor Progression Jorge Martinez 1,* and Patricio C. Smith 2,* 1 Cell Biology Laboratory, INTA, University of Chile, Santiago 7810000, Chile 2 School of Dentistry, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago 8330024, Chile * Correspondence: [email protected] (J.M.); [email protected] (P.C.S.); Tel.: + 56-2-2987-1419 (J.M.); +56-2-2354-8400 (P.C.S.) Abstract: Desmoplastic tumors correspond to a unique tissue structure characterized by the abnormal deposition of extracellular matrix. Breast tumors are a typical example of this type of lesion, a property that allows its palpation and early detection. Fibrillar type I collagen is a major component of tumor desmoplasia and its accumulation is causally linked to tumor cell survival and metastasis. For many years, the desmoplastic phenomenon was considered to be a reaction and response of the host tissue against tumor cells and, accordingly, designated as “desmoplastic reaction”. This notion has been challenged in the last decades when desmoplastic tissue was detected in breast tissue in the absence of tumor. This finding suggests that desmoplasia is a preexisting condition that stimulates the development of a malignant phenotype. With this perspective, in the present review, we analyze the role of extracellular matrix remodeling in the development of the desmoplastic response. Importantly, during the discussion, we also analyze the impact of obesity and cell metabolism as critical drivers of tissue remodeling during the development of desmoplasia. New knowledge derived from the dynamic remodeling of the extracellular matrix may lead to novel targets of interest for early diagnosis or therapy in the context of breast tumors.
    [Show full text]
  • Blood Vitronectin Is a Major Activator of LIF and IL-6 in the Brain Through Integrin–FAK and Upar Signaling Matthew P
    © 2018. Published by The Company of Biologists Ltd | Journal of Cell Science (2018) 131, jcs202580. doi:10.1242/jcs.202580 RESEARCH ARTICLE Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin–FAK and uPAR signaling Matthew P. Keasey1, Cuihong Jia1, Lylyan F. Pimentel1,2, Richard R. Sante1, Chiharu Lovins1 and Theo Hagg1,* ABSTRACT Microglia and astrocytes express the VTN receptors αvβ3 and α β We defined how blood-derived vitronectin (VTN) rapidly and potently v 5 integrin (Herrera-Molina et al., 2012; Kang et al., 2008; activates leukemia inhibitory factor (LIF) and pro-inflammatory Milner, 2009; Welser-Alves et al., 2011). Microglia and astrocytes, interleukin 6 (IL-6) in vitro and after vascular injury in the brain. as well as endothelial cells, are major producers of pro- α in vitro Treatment with VTN (but not fibrinogen, fibronectin, laminin-111 or inflammatory cytokines, such as IL-6 and TNF , and collagen-I) substantially increased LIF and IL-6 within 4 h in after traumatic or ischemic injury to the brain (Banner et al., 1997; C6-astroglioma cells, while VTN−/− mouse plasma was less effective Erta et al., 2012; Lau and Yu, 2001) or upon self-induction by IL-6 than that from wild-type mice. LIF and IL-6 were induced by (Van Wagoner and Benveniste, 1999). IL-6 is a major regulator of a intracerebral injection of recombinant human (rh)VTN in mice, but variety of inflammatory disorders and a target for therapies (Hunter induction seen upon intracerebral hemorrhage was less in VTN−/− and Jones, 2015).
    [Show full text]
  • Cell Adhesion Molecules in Normal Skin and Melanoma
    biomolecules Review Cell Adhesion Molecules in Normal Skin and Melanoma Cian D’Arcy and Christina Kiel * Systems Biology Ireland & UCD Charles Institute of Dermatology, School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland; [email protected] * Correspondence: [email protected]; Tel.: +353-1-716-6344 Abstract: Cell adhesion molecules (CAMs) of the cadherin, integrin, immunoglobulin, and selectin protein families are indispensable for the formation and maintenance of multicellular tissues, espe- cially epithelia. In the epidermis, they are involved in cell–cell contacts and in cellular interactions with the extracellular matrix (ECM), thereby contributing to the structural integrity and barrier for- mation of the skin. Bulk and single cell RNA sequencing data show that >170 CAMs are expressed in the healthy human skin, with high expression levels in melanocytes, keratinocytes, endothelial, and smooth muscle cells. Alterations in expression levels of CAMs are involved in melanoma propagation, interaction with the microenvironment, and metastasis. Recent mechanistic analyses together with protein and gene expression data provide a better picture of the role of CAMs in the context of skin physiology and melanoma. Here, we review progress in the field and discuss molecular mechanisms in light of gene expression profiles, including recent single cell RNA expression information. We highlight key adhesion molecules in melanoma, which can guide the identification of pathways and Citation: D’Arcy, C.; Kiel, C. Cell strategies for novel anti-melanoma therapies. Adhesion Molecules in Normal Skin and Melanoma. Biomolecules 2021, 11, Keywords: cadherins; GTEx consortium; Human Protein Atlas; integrins; melanocytes; single cell 1213. https://doi.org/10.3390/ RNA sequencing; selectins; tumour microenvironment biom11081213 Academic Editor: Sang-Han Lee 1.
    [Show full text]
  • Ivtigation of the Effects of Mechanical Strain in Human Tenocytes
    Investigation of the effects of Mechanical Strain in Human Tenocytes Eleanor Rachel Jones In partial fulfilment of the requirements for the Degree of Doctor of Philosophy University of East Anglia, Biological Sciences September 2012 This copy of the thesis has been supplied on condition that anyone who consults it is understood to recognise that its copyright rests with the author and that use of any information derived there from must be in accordance with current UK Copyright Law. In addition, any quotation or extract must be included full attribution. Abstract Tendinopathies are a range of diseases characterised by pain and insidious degeneration. Although poorly understood, onset is often associated with physical activity. Metalloproteinases are regulated differentially in tendinopathy causing disruptions in extracellular matrix (ECM) homeostasis. An increase in the anti-inflammatory cytokine TGFβ has also been documented. This project aims to investigate the effect of cyclic tensile strain loading and TGFβ stimulation on protease and ECM protein expression by human tenocytes and begin to characterise the pathway of mechanotransduction. Human tenocytes were seeded at 1.5x106 cells/ml into collagen gels (rat tail type I, 1mg/ml) and stretched using a sinusoidal waveform of 0-5% at 1Hz using the Flexcell FX4000T™ system. Cultures were treated with or without 1ng/ml TGFβ1 or inhibitors of TGFβRI, metalloproteinases, RGD, Mannose-6-phosphate, integrin β1 and a thrombospondin as appropriate. qRT-PCR and a cell based luciferase assay were used to assess RNA and TGFβ activity respectively. The prolonged application of 5% cyclic mechanical strain in a 3D culture system induced an anabolic response in protease and matrix genes.
    [Show full text]
  • Tenascins in Stem Cell Niches
    MATBIO-01031; No of Pages 12 Matrix Biology xxx (2014) xxx–xxx Contents lists available at ScienceDirect Matrix Biology journal homepage: www.elsevier.com/locate/matbio Tenascins in stem cell niches Ruth Chiquet-Ehrismann a,b,⁎,1,GertraudOrendc,d,e,f,1, Matthias Chiquet g,1, Richard P. Tucker h,1, Kim S. Midwood i,1 a Friedrich Miescher Institute of Biomedical Research, Novartis Research Foundation, Maulbeerstrasse 66 CH-4058 Basel, Switzerland b Faculty of Sciences, University of Basel, Switzerland c Inserm U1109, The Microenvironmental Niche in Tumorigenesis and Targeted Therapy (MNT3) Team, 3 av. Molière, 67200 Strasbourg, France d Université de Strasbourg, 67000 Strasbourg, France e LabEx Medalis, Université de Strasbourg, 67000 Strasbourg, France f Fédération de Médecine Translationnelle de Strasbourg (FMTS), 67000 Strasbourg, France g Department of Orthodontics and Dentofacial Orthopedics, University of Bern, Freiburgstrasse 7, CH-3010 Bern, Switzerland h Department of Cell Biology and Human Anatomy, University of California Davis, Davis, CA 95616, USA i The Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Headington, Oxford OX3 7FY, United Kingdom article info abstract Available online xxxx Tenascins are extracellular matrix proteins with distinct spatial and temporal expression during development, tissue homeostasis and disease. Based on their expression patterns and knockout phenotypes an important Keywords: role of tenascins in tissue formation, cell adhesion modulation, regulation of proliferation and
    [Show full text]
  • Downregulation of Lysyl Oxidase and Lysyl Oxidase-Like Protein 2
    Xu et al. Experimental & Molecular Medicine (2019) 51:20 https://doi.org/10.1038/s12276-019-0211-9 Experimental & Molecular Medicine ARTICLE Open Access Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia Xiang-Hong Xu 1,YuanhuiJia1,XinyaoZhou1,DandanXie1, Xiaojie Huang1, Linyan Jia1, Qian Zhou1, Qingliang Zheng1, Xiangyu Zhou1,KaiWang1 and Li-Ping Jin1 Abstract Preeclampsia is a pregnancy-specific disorder that is a major cause of maternal and fetal morbidity and mortality with a prevalence of 6–8% of pregnancies. Although impaired trophoblast invasion in early pregnancy is known to be closely associated with preeclampsia, the underlying mechanisms remain elusive. Here we revealed that lysyl oxidase (LOX) and LOX-like protein 2 (LOXL2) play a critical role in preeclampsia. Our results demonstrated that LOX and LOXL2 expression decreased in preeclamptic placentas. Moreover, knockdown of LOX or LOXL2 suppressed trophoblast cell migration and invasion. Mechanistically, collagen production was induced in LOX-orLOXL2-downregulated trophoblast cells through activation of the TGF-β1/Smad3 pathway. Notably, inhibition of the TGF-β1/Smad3 pathway 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; could rescue the defects caused by LOX or LOXL2 knockdown, thereby underlining the significance of the TGF-β1/ Smad3 pathway downstream of LOX and LOXL2 in trophoblast cells. Additionally, induced collagen production and activated TGF-β1/Smad3 were observed in clinical samples from preeclamptic placentas. Collectively, our study suggests that the downregulation of LOX and LOXL2 leading to reduced trophoblast cell migration and invasion through activation of the TGF-β1/Smad3/collagen pathway is relevant to preeclampsia.
    [Show full text]